800 participants
Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-19
- Start Date:
- 2012-06-17
- Completion:
- 2014-01-31
Conditions
- Colorectal Cancer
Interventions
- DRUG